Genetic Sequencing Could Augment Newborn Screening
BGI Genomics
Approximately 1 in 500 newborns benefited from gene panel sequencing integration into first-tier screening tests
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
Easy-to-implement technology reduces the per-reaction cost of target capture by two to three orders of magnitude as compared to commercial solutions